173 related articles for article (PubMed ID: 16670084)
1. Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells.
Wai PY; Mi Z; Gao C; Guo H; Marroquin C; Kuo PC
J Biol Chem; 2006 Jul; 281(28):18973-82. PubMed ID: 16670084
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
[TBL] [Abstract][Full Text] [Related]
3. The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin.
Shen Q; Christakos S
J Biol Chem; 2005 Dec; 280(49):40589-98. PubMed ID: 16195230
[TBL] [Abstract][Full Text] [Related]
4. Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription.
El-Tanani M; Platt-Higgins A; Rudland PS; Campbell FC
J Biol Chem; 2004 May; 279(20):20794-806. PubMed ID: 14990565
[TBL] [Abstract][Full Text] [Related]
5. Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells.
Takami Y; Russell MB; Gao C; Mi Z; Guo H; Mantyh CR; Kuo PC
Surgery; 2007 Aug; 142(2):163-9. PubMed ID: 17689681
[TBL] [Abstract][Full Text] [Related]
6. Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells.
Georges R; Adwan H; Zhivkova M; Eyol E; Bergmann F; Berger MR
Int J Oncol; 2010 Aug; 37(2):249-56. PubMed ID: 20596651
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells.
Liu YN; Kang BB; Chen JH
Oncogene; 2004 Jan; 23(1):278-88. PubMed ID: 14712233
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
[TBL] [Abstract][Full Text] [Related]
9. Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell.
Guo X; Zhang YP; Mitchell DA; Denhardt DT; Chambers AF
Mol Cell Biol; 1995 Jan; 15(1):476-87. PubMed ID: 7799957
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions.
Wang D; Yamamoto S; Hijiya N; Benveniste EN; Gladson CL
Oncogene; 2000 Nov; 19(50):5801-9. PubMed ID: 11126367
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the osteopontin promoter affect its transcriptional activity.
Giacopelli F; Marciano R; Pistorio A; Catarsi P; Canini S; Karsenty G; Ravazzolo R
Physiol Genomics; 2004 Dec; 20(1):87-96. PubMed ID: 15479859
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities.
Bidder M; Shao JS; Charlton-Kachigian N; Loewy AP; Semenkovich CF; Towler DA
J Biol Chem; 2002 Nov; 277(46):44485-96. PubMed ID: 12200434
[TBL] [Abstract][Full Text] [Related]
13. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the promoter region of the porcine opn (osteopontin, secreted phosphoprotein 1) gene. Identification of positive and negative regulatory elements and a 'silent' second promoter.
Zhang Q; Wrana JL; Sodek J
Eur J Biochem; 1992 Jul; 207(2):649-59. PubMed ID: 1633816
[TBL] [Abstract][Full Text] [Related]
15. Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases.
Mole DJ; O'Neill C; Hamilton P; Olabi B; Robinson V; Williams L; Diamond T; El-Tanani M; Campbell FC
Br J Cancer; 2011 Mar; 104(6):1007-12. PubMed ID: 21343932
[TBL] [Abstract][Full Text] [Related]
16. The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression.
Inman CK; Shore P
J Biol Chem; 2003 Dec; 278(49):48684-9. PubMed ID: 14506237
[TBL] [Abstract][Full Text] [Related]
17. The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis.
Villanueva F; Araya H; Briceño P; Varela N; Stevenson A; Jerez S; Tempio F; Chnaiderman J; Perez C; Villarroel M; Concha E; Khani F; Thaler R; Salazar-Onfray F; Stein GS; van Wijnen AJ; Galindo M
J Cell Physiol; 2019 Aug; 234(8):13659-13679. PubMed ID: 30637720
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of the ERG transcription factor in prostate cancer cells activates osteopontin.
Flajollet S; Tian TV; Flourens A; Tomavo N; Villers A; Bonnelye E; Aubert S; Leroy X; Duterque-Coquillaud M
Mol Cancer Res; 2011 Jul; 9(7):914-24. PubMed ID: 21669963
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the osteopontin gene by the orphan nuclear receptor NURR1 in osteoblasts.
Lammi J; Huppunen J; Aarnisalo P
Mol Endocrinol; 2004 Jun; 18(6):1546-57. PubMed ID: 14988426
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation.
Wai PY; Guo L; Gao C; Mi Z; Guo H; Kuo PC
Surgery; 2006 Aug; 140(2):132-40. PubMed ID: 16904962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
